financetom
Business
financetom
/
Business
/
Canaccord Genuity Group Reports Non-Brokered Private Placement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canaccord Genuity Group Reports Non-Brokered Private Placement
Mar 8, 2024 5:14 AM

07:53 AM EST, 03/08/2024 (MT Newswires) -- Canaccord Genuity Group Inc. ( CCORF ) overnight Thursday said that it plans to raise gross proceeds of $110 million by issuing convertible unsecured senior subordinated debentures via a non-brokered private placement to two institutional investors.

The offering is expected to close by March 15.

The debentures will bear interest at a rate of 7.75% per annum, payable semi-annually on the last day of June and December each year starting June 30, 2024. The debentures will be convertible at the holder's option into common shares of the company, at a conversion price of $9.68 per common share. The debentures will mature five years from the date of issue and may be redeemed in certain circumstances, by the third anniversary of the issue date.

Canaccord Genuity Group ( CCORF ) plans to use about $80 million of the proceeds to provide an interest-bearing loan to an independent, limited partnership to be owned by certain employees of the company.

The partnership will be a long-term ownership vehicle for senior employees of the company and will use the loan proceeds to buy about 9.9 million outstanding common shares in a private transaction to be completed contemporaneously with the closing of the private placement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved